pfizer

OTTAWA -- A Manitoba MP fears the reputation of the agency responsible for funding health research in Canada is in jeopardy after a House of Commons committee rejected her motion to try to quash the appointment of a drug company executive to the institute's board.The health committee Monday debated the qualifications of Dr. Bernard Prigent, vice-president and medical director of Pfizer Canada, to the governing council of the Canadian Institutes for Health Research. His appointment was announced by Health Minister Leona Aglukkaq in October but an outpouring of concern, including a petition with over 3,600 signatures, led the committee to take it upon itself to review Prigent's credentials.